Back

Antihypertensive treatment during pregnancy and maternal and fetal outcomes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Pharmacological management of hypertension Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Jan Vaclavik

University Hospital Ostrava, Ostrava (Czechia)

5 More presentations in this session

Presentation thumbnail
Subgroup results from KARDIA-2: impact of demographic and baseline disease characteristics on zilebesiran response in patients with hypertension uncontrolled by a standard oral antihypertensive
Doctor M. Saxena (London, GB)
Abstract Slides Video
Presentation thumbnail
Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial
Professor H. Chen (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Antihypertensive treatment of masked hypertension guided by ambulatory blood pressure monitoring: a double-blind, placebo-controlled trial
Doctor D. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up
Doctor S. Jo (Anyang-Si- Gyeonggi-Do, KR)
Abstract Slides Video
Presentation thumbnail
Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials
Doctor N. Wang (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacological management of hypertension
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources